Skin microbiome guide: what lives on your skin and how it affects skin health

The skin hosts approximately 1.8 m² of ecosystem — one of the most complex microbial communities in the human body, comprising bacteria, fungi, viruses, and mites coexisting in an environment shaped by sebum, sweat, pH, temperature, and the host immune system. This microbiome is not incidental to skin health: disruption of specific microbial communities is directly causative in several common skin conditions. Here is the evidence-based guide.

The skin microbiome: basic architecture

Microbial niches on the skin

The skin is not a uniform environment. Different body sites have dramatically different microbiomes based on their local chemistry:

Sebaceous (oily) sites (face, scalp, upper chest, upper back):

Dominated by Cutibacterium acnes (formerly Propionibacterium acnes) — a lipophilic, slow-growing anaerobe that thrives in sebum-rich follicles
Malassezia spp. fungi — obligate lipophilic yeasts that colonize the sebaceous follicle; present on virtually all adults

Moist sites (axillae, inguinal folds, antecubital fossae, toe webs):

Staphylococcus spp. (coagulase-negative staphylococci, particularly S. epidermidis)
Corynebacterium spp.
S. aureus — normally absent or present at very low abundance; elevated in disease states

Dry sites (forearms, palms, legs):

Most diverse microbiome community
Mixed Actinobacteria, Proteobacteria, Firmicutes, Bacteroidetes

The acid mantle and pH

Healthy skin surface pH is approximately 4.5–5.5 (the "acid mantle"). This mildly acidic environment:

Favors the growth of commensal organisms (S. epidermidis, C. acnes in low abundance)
Inhibits S. aureus and many other pathogens that prefer neutral pH
Maintains optimal activity of skin lipid-processing enzymes and antimicrobial peptides (AMPs)

What raises skin pH: soap-based cleansers (pH 9–10), harsh detergents, excessive water exposure. Sustained pH elevation favors pathogen colonization and disrupts barrier enzyme function.

The skin microbiome in specific skin conditions

Atopic dermatitis: the S. aureus dysbiosis

The most clinically significant microbiome-disease relationship in dermatology is the role of Staphylococcus aureus in atopic dermatitis (AD):

Normal skin: S. aureus colonization is low or absent; S. epidermidis dominates staphylococcal niches.

AD skin: S. aureus colonizes the skin of >90% of AD patients; in flares, S. aureus can comprise >90% of the total skin microbiome on affected areas.

The mechanism:

Filaggrin deficiency (genetic or inflammation-driven) → barrier disruption → S. aureus can adhere and colonize
S. aureus produces superantigens (SEB, TSST-1) that activate T cells non-specifically → amplified Th2/Th17 inflammation → worsens barrier disruption
S. aureus produces ceramidases and lipases that degrade the barrier lipid matrix → further barrier compromise
S. aureus suppresses AMPs by downregulating host cathelicidin and β-defensin production → reduces the host's ability to limit colonization
Vicious cycle: Barrier breaks → S. aureus → more inflammation → more barrier disruption → more S. aureus

Clinical implication: Dilute bleach baths (sodium hypochlorite 0.005%, equivalent to ~1 teaspoon bleach per 4 gallons water) significantly reduce S. aureus skin burden → reduce AD flares. Huang 2009 (Pediatrics) RCT: bleach baths significantly improved AD severity scores vs. plain water baths.

The S. epidermidis counter-effect: Commensal S. epidermidis produces serine protease Esp that inhibits S. aureus biofilm formation and nasal colonization. Loss of S. epidermidis in AD creates a niche for S. aureus expansion.

Acne: Cutibacterium acnes phylotype dysbiosis

Important reframe: It is not the presence of C. acnes that causes acne — C. acnes is present on virtually all adult skin regardless of acne status. The critical factor is the phylotype distribution:

Health-associated phylotypes (IA2, II, III): Associated with clear skin in microbiome studies
Acne-associated phylotypes (IA1): Dominant in acne patients; associated with higher virulence factor expression — porphyrins (inducing oxidative stress), lipases (hydrolysing sebum triglycerides → proinflammatory free fatty acids), biofilm formation

The acne microenvironment: Sebum excess + follicular hyperkeratosis → anaerobic, lipid-rich follicular environment → shifts the balance toward acne-associated phylotypes → inflammation

Antibiotic implications: Long-term oral antibiotics shift the C. acnes phylotype distribution — but also disrupt the broader skin and gut microbiome and select for resistance. Combined BPO (which cannot select resistance) + antibiotic is the standard approach.

Seborrheic dermatitis: Malassezia dysbiosis

Malassezia spp. are obligate lipophilic yeasts present on virtually all adults. In seborrheic dermatitis, Malassezia species with high lipase activity (particularly M. restricta and M. globosa) cleave oleic acid from sebum triglycerides → oleic acid penetrates the barrier → disrupts keratinocyte differentiation → drives the inflammatory cascade → scaling and erythema. See the Seborrheic Dermatitis guide for the full treatment protocol.

What disrupts the skin microbiome

Antibacterial soaps and harsh cleansers

Antibacterial agents (triclosan — now largely banned in the US; benzalkonium chloride; high-pH soaps) non-selectively reduce skin bacterial load — including the beneficial S. epidermidis and commensal organisms that occupy niches against S. aureus colonization. The FDA banned triclosan from consumer soaps in 2016 citing lack of demonstrated safety benefit.

Plain soap or gentle surfactant cleansers at appropriate pH do not significantly alter the microbiome in the same way.

Over-exfoliation

Aggressive physical or chemical exfoliation removes both the stratum corneum barrier and the commensal microbiome community. The recovery microbiome after barrier disruption may be less diverse and less health-associated than the stable resident community.

Antibiotics (topical and oral)

Topical clindamycin and erythromycin significantly alter the skin microbiome composition — selecting for resistant C. acnes strains and reducing overall diversity. This is the mechanistic basis for combining topical antibiotics with BPO (which non-specifically reduces all bacterial load and cannot select resistance).

Oral antibiotics impact both the skin and gut microbiome — the gut microbiome recovers in weeks; skin microbiome recovery is less well-studied.

What does NOT disrupt the microbiome significantly

Retinoids: Do not significantly alter the skin microbiome composition in clinical studies despite their anti-C. acnes mechanism (which operates through comedolysis and anti-inflammatory action, not direct bactericidal activity).

SPF: No evidence of meaningful microbiome disruption from mineral or organic UV filters at normal use concentrations.

Probiotic and prebiotic skincare: the evidence

Topical probiotics: promise and reality

The concept: applying live Lactobacillus or S. epidermidis to skin to directly increase commensal populations — competitive exclusion of S. aureus; restoration of depleted commensals.

The evidence:

Small RCTs with topical S. epidermidis lysates have shown reduction in S. aureus colonization in AD skin
Lactobacillus-containing topical formulations have shown mixed results in small studies for AD and acne
Limitation: live bacteria in cosmetic formulations are difficult to stabilize; many "probiotic" skincare products contain only inactivated bacteria or lysates, not live colonies

Honest assessment: Mechanistically plausible; the clinical evidence base is growing but not yet sufficient for strong recommendations. Topical probiotic skincare is unlikely to cause harm and may provide benefit for sensitive or reactive skin; it is not a substitute for proven treatments for conditions like AD or acne.

Oral probiotics and skin

Oral Lactobacillus rhamnosus GG, L. reuteri, and Bifidobacterium strains have been studied for atopic dermatitis prevention and treatment. The evidence is mixed:

Some RCTs show significant reduction in AD incidence when L. rhamnosus GG is given to high-risk infants
Evidence for treating established AD in older children and adults is weaker and inconsistent
Cochrane 2018 review: probiotics may reduce AD severity in infants but evidence quality is low-to-moderate

Honest assessment: Prenatal and early-life oral probiotic use may reduce AD risk in high-risk infants (those with family history); the evidence for treating established adult AD is insufficient to recommend as primary therapy.

Supporting the skin microbiome

Clinically supported approaches:

Maintain skin pH with gentle, pH-appropriate cleansers (pH 4.5–5.5)
Avoid antibacterial soaps for routine skin cleansing
Use targeted antibiotics only when clinically indicated; minimize duration
Dilute bleach baths for AD patients to reduce S. aureus burden
Moisturize consistently with ceramide-based products — a healthy barrier supports a stable commensal community

Avoid marketing-driven claims: The skin microbiome has become a marketing hook for products with limited or no evidence of clinical benefit. Fermented ingredients, "biome-friendly" claims, and probiotic counts on packaging are not independently validated indicators of skin microbiome benefit.

Looking for a skincare or dermatology consultation? Browse med spa providers on MedSpot →